Fraud Alert

Gateway Pharmacy and Sarhaddi Pharmaceutical Inc. are aware of fraudulent emails
and websites falsely offering employment opportunities in our name.

We never request payment from applicants. If you receive suspicious communications claiming
to represent our company, please contact us directly to verify authenticity.

Get Healthy!

  • Posted December 16, 2025

Is Tamoxifen Alone a Viable Option for Women with Low-Risk DCIS Breast Cancer?

In a new study, women with very early-stage DCIS breast cancer taking tamoxifen alone had higher recurrence rates than researchers expected. But they say the incidence of invasive breast cancer was still low at 5 years, suggesting tamoxifen alone may be an option in “carefully selected patients.”

Health News is provided as a service to Gateway Pharmacy site users by HealthDay. Gateway Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2026 HealthDay All Rights Reserved.